Your browser doesn't support javascript.
loading
Anti-IgE and Biologic Approaches for the Treatment of Asthma.
Mitchell, Patrick D; El-Gammal, Amani I; O'Byrne, Paul M.
Afiliação
  • Mitchell PD; Firestone Institute for Respiratory Health and the Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • El-Gammal AI; Firestone Institute for Respiratory Health and the Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • O'Byrne PM; Firestone Institute for Respiratory Health and the Department of Medicine, McMaster University, Hamilton, ON, Canada. obyrnep@mcmaster.ca.
Handb Exp Pharmacol ; 237: 131-152, 2017.
Article em En | MEDLINE | ID: mdl-27864676
ABSTRACT
Current asthma treatments are effective for the majority of patients with mild-to-moderate disease. However, in those with more severe refractory asthma, agents other than inhaled corticosteroids and beta-agonists are needed both to better manage this group of patients and to avoid the side effects of high-dose corticosteroids and the social and personal hardship endured. Several biological pathways have been targeted over the last 20 years, and this research has resulted in pharmacological approaches to attempt to better treat patients with severe refractory asthma. The flagship of the biologics, the anti-IgE monoclonal antibody, omalizumab, has proven efficacious in selected subgroups of asthma patients. Tailoring asthma treatments to suit specific subtypes of asthma patients is in keeping with ideals of personalized medicine. Research in the complex interplay of allergens, epithelial host defenses, cytokines, and innate and adaptive immunity interactions has allowed better understanding of the mechanics of allergy and inflammation in asthma. As a result, new biologic treatments have been developed that target several different phenotypes and endotypes in asthma. As knowledge of the efficacy of these biological agents in asthma emerges, as well as the type of patients in whom they are most beneficial, the movement toward personalized asthma treatment will follow.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Fatores Biológicos / Anticorpos Anti-Idiotípicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Fatores Biológicos / Anticorpos Anti-Idiotípicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article